| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/24/2003 | WO2003106985A1 Flammable vapor sensor |
| 12/24/2003 | WO2003106980A1 Universal quantitative organic molecule detector using fluorescence, which is characterised by ion-induced dipole interactions |
| 12/24/2003 | WO2003106975A1 Gas detection device |
| 12/24/2003 | WO2003106974A2 Diagnosis and treatment of chemoresistant tumors |
| 12/24/2003 | WO2003106970A2 P27 prevents cellular migration |
| 12/24/2003 | WO2003106968A2 Test strip for detection of analyte and methods of use |
| 12/24/2003 | WO2003106967A2 Method of evaluating myelosuppressive state |
| 12/24/2003 | WO2003106966A2 Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods |
| 12/24/2003 | WO2003106964A2 High throughput methods and devices for assaying analytes in a fluid sample |
| 12/24/2003 | WO2003106962A2 A coated film laminate having an electrically conductive surface |
| 12/24/2003 | WO2003106943A1 Metal coated nanocrystalline silicon as an active surface enhanced raman spectroscopy (sers) substrate |
| 12/24/2003 | WO2003106704A1 Method for identifying intracellular transport modulators by measuring the expression or activity of neutral sphingomyelinase |
| 12/24/2003 | WO2003106703A2 Homogenous assay for enzymatic activity |
| 12/24/2003 | WO2003106701A1 Non-invasive analysis and detection of micro-organisms in dairy products contained in laminated paper or carton containers, using elastic waves by means of dry coupling |
| 12/24/2003 | WO2003106699A1 Bacterial test method by glycated label binding |
| 12/24/2003 | WO2003106698A1 Method and system for disclosing mechanism-based enzyme inhibitors |
| 12/24/2003 | WO2003106697A2 Method and kit for identifying pseudomonas aeruginosa |
| 12/24/2003 | WO2003106694A2 Rapid methods for assessing therapeutic activity using animals expressing constitutively active g protein-coupled receptors |
| 12/24/2003 | WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | WO2003106683A1 Novel screening method |
| 12/24/2003 | WO2003106668A1 Glucose dehydrogenase |
| 12/24/2003 | WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | WO2003106656A2 Single domain tdf-related compounds and analogs thereof |
| 12/24/2003 | WO2003106655A2 Fibrous protein-immobilization systems |
| 12/24/2003 | WO2003106649A2 Assay conjugate and uses thereof |
| 12/24/2003 | WO2003106639A2 Recombination of nucleic acid library members |
| 12/24/2003 | WO2003106624A2 Cancer-linked gene as target for chemotherapy |
| 12/24/2003 | WO2003106623A2 Early noninvasive prenatal test for aneuploidies and heritable conditions |
| 12/24/2003 | WO2003106621A2 Anti-igf-i receptor antibody |
| 12/24/2003 | WO2003106589A1 A nanoporous particle with a retained target |
| 12/24/2003 | WO2003106498A2 Agonistic binding molecules to the human ox40 receptor |
| 12/24/2003 | WO2003106493A1 Protein analysis |
| 12/24/2003 | WO2003106492A1 Marker for stem cells and its use |
| 12/24/2003 | WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | WO2003105891A2 Use of hec1 antagonists in the treatment of proliferative disorders and cancer |
| 12/24/2003 | WO2003105887A1 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 12/24/2003 | WO2003105886A2 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation |
| 12/24/2003 | WO2003105884A1 Use of shp-1 for the therapy of asthma |
| 12/24/2003 | WO2003105879A1 Compositions and methods for preventing, treating and diagnosing diabetes |
| 12/24/2003 | WO2003105835A1 Methods of use for tripeptidyl peptidase ii inhibitors as anticancer agents |
| 12/24/2003 | WO2003105783A2 Cancer-linked gene as target for chemotherapy |
| 12/24/2003 | WO2003105773A2 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets: |
| 12/24/2003 | WO2003105763A2 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 12/24/2003 | WO2003105758A2 Cancer-linked gene as target for chemotherapy |
| 12/24/2003 | WO2003105757A2 Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| 12/24/2003 | WO2003105694A1 Temporary tattoo for testing the sensitivity of skin to chemicals |
| 12/24/2003 | WO2003105675A2 Computerized image capture of structures of interest within a tissue sample |
| 12/24/2003 | WO2003105666A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 12/24/2003 | WO2003105660A2 Method for determining pathosis of biological objects |
| 12/24/2003 | WO2003105591A1 Method for identifying fungicidally active compounds |
| 12/24/2003 | WO2003105578A1 Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide |
| 12/24/2003 | WO2003105561A2 Method and devices for diagnosing and treating choroid plexus failure |
| 12/24/2003 | WO2003093784A9 Liaison superficielle d'immunoglobuline sur polymere flexible, au moyen d'une matrice de vernis hydrosoluble |
| 12/24/2003 | WO2003089465A3 Crystals structure of the mouse apoptosis-inducing factor aif and applications thereof |
| 12/24/2003 | WO2003087133A3 Improved methods for high-resolution identification of solvent-accessible amide hydrogens in polypeptides and for characterization of polypeptide structure |
| 12/24/2003 | WO2003083136B1 Method and kit for detecting membrane protein-protein interactions |
| 12/24/2003 | WO2003083113A3 Growth regulating proteins |
| 12/24/2003 | WO2003082469A3 Device and method for carrying out and continuously monitoring chemical and/or biological reactions |
| 12/24/2003 | WO2003082091A3 Integrated sample testing meter |
| 12/24/2003 | WO2003081223A3 Sensors with variable response behavior |
| 12/24/2003 | WO2003079020A3 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer |
| 12/24/2003 | WO2003079012A3 Serological method for detecting intestinal microvilli atrophy in patients suffering from coeliac disease |
| 12/24/2003 | WO2003078451A3 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby |
| 12/24/2003 | WO2003076897A3 Multiplexed analysis of cellular responses using endogenous reporter genes |
| 12/24/2003 | WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 12/24/2003 | WO2003075014A3 Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11 |
| 12/24/2003 | WO2003069304A3 Method and apparatus for assay of electrochemical properties |
| 12/24/2003 | WO2003068925A3 Production of a protein delivery system for in vivo therapeutic treatment |
| 12/24/2003 | WO2003068913A3 Synthesis of 2h- and 13c- substituted dithianes |
| 12/24/2003 | WO2003066845A3 Bacteriophage lysin |
| 12/24/2003 | WO2003066840A3 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 12/24/2003 | WO2003066048A3 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss |
| 12/24/2003 | WO2003065044A8 Diagnostics and therapeutics for diseases associated with gpr72 |
| 12/24/2003 | WO2003064690A3 Process for detecting predisposition to a cardiovascular disease |
| 12/24/2003 | WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene |
| 12/24/2003 | WO2003064681A3 Assays |
| 12/24/2003 | WO2003064473A3 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 12/24/2003 | WO2003061567A3 Selective s1p1/edg1 receptor agonists |
| 12/24/2003 | WO2003060517A3 Diffusable adhesive composition for multi-layered dry reagent devices |
| 12/24/2003 | WO2003060460A3 Multi-target screening |
| 12/24/2003 | WO2003059936A3 Phytophthora Infestans CDC 14 Phosphatase Gene, Protein and Methods of Use |
| 12/24/2003 | WO2003053535A9 Nanoparticle imaging system and method |
| 12/24/2003 | WO2003047611A3 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 12/24/2003 | WO2003046509A3 Capsule and tray systems for combined sample collection, archiving, purification, and pcr |
| 12/24/2003 | WO2003042394A3 Bag-1 mediated down-regulation of glucocorticoid-receptor transactivation |
| 12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/24/2003 | WO2003027322A3 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 12/24/2003 | WO2003025154A3 Methods and compositions for the construction and use of fusion libraries |
| 12/24/2003 | WO2003022990A3 Production of fusion proteins and use for identifying binding molecules |
| 12/24/2003 | WO2003020220A3 Mitochondrial biology expression arrays |
| 12/24/2003 | WO2003014302A3 Detection of differential expression of protein using gel-free proteomics |
| 12/24/2003 | WO2003005033A3 Carcinoma-related peptides |
| 12/24/2003 | WO2002102990A8 Fibroblast growth factor and nucleic acid encoding same |
| 12/24/2003 | WO2002096929A3 Polypeptides reacting with hcv-infected patients' antibodies and uses |
| 12/24/2003 | WO2002092764A3 Transgenic animal model of bone mass modulation |
| 12/24/2003 | WO2002090542A3 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 12/24/2003 | WO2002088170A3 Cripto blocking antibodies and uses thereof |
| 12/24/2003 | WO2002083846A8 Methods of analysis and labeling of protein-protein interactions |
| 12/24/2003 | WO2002077186A3 Human secreted proteins |
| 12/24/2003 | WO2002064840A3 Methods for identifying compounds that inhibit or reduce ptp1b expression |